ARCHIVES

In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request

This article is from The Cancer Letter archive.

Vol. 12 No. 44 | November 14, 1986

Download PDF Visit The Full Archive

Related Articles

FDA cancer therapeutics review split among three units in reorganization.

October 10, 2003

Bristol-Myers Runs Afoul Of FDA In Attempt To Distribute Chapters of Oncology Textbook

June 19, 1992

Program Announcements

July 25, 1986

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014